Revolution Medicines Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Thanks for joining the next session with Revolution Medicines. I'm Ami Fadia, one of the biotech analysts here at Needham. (Operator Instructions) And with that, it's my pleasure to be hosting Mark Goldsmith, President and CEO of the company. Mark, thank you for taking the time today.
Thank you. Appreciate the opportunity to speak with you.
Perfect.
Questions & Answers
Perhaps what would be good to do, is just start with an overview of the company for those who are not familiar, but just sort of by way of context, I think the world of KRAS, has been fairly, sort of, in the lime light over the last couple of years as we've seen the first two KRAS-G12C products come to market. Perhaps, maybe if you could start by helping the audience understand how Revolution Medicine's approach is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
